Lataa...
Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition
Recent clinical data indicate a synergistic therapeutic effect between trastuzumab and taxanes in neoadjuvantly treated HER2-positive breast cancer (BC) patients. In HER2+ BC experimental models and patients, we investigated whether this synergy depends on the ability of drug-induced stress to impro...
Tallennettuna:
Julkaisussa: | Oncotarget |
---|---|
Päätekijät: | , , , , , , , , , , |
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
Impact Journals LLC
2015
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4807996/ https://ncbi.nlm.nih.gov/pubmed/26595802 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|